Canakinumab treatment in patients with active recurrent or chronic TNF-receptor associated syndrome (TRAPS): Efficacy and safety results from a proof of concept study

Detalles Bibliográficos
Autores principales: Lachmann, H, Cattalini, M, Obici, L, Barcellona, R, Speziale, A, Joubert, Y, Junge, G, Gattorno, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597075/
http://dx.doi.org/10.1186/1546-0096-13-S1-O59
Descripción
Sumario:

Ejemplares similares